文献速递生殖医学

精液参数阈值与受孕时间:亚 fertile 夫妇中总前向运动精子计数50百万的预测价值

Semen parameter thresholds and time-to-conception in subfertile couples: how high is high enough?
PubMed 文献 · Hum Reprod · 2021-01-01

该纵向队列研究纳入2002-2017年6061名亚fertile男性,分析总精子数、浓度、前向运动力和总前向运动精子计数(TPMC)与5年内受孕时间的关系。结果显示TPMC≥50百万者5年内受孕几率高45%(HR 1.45, 95%CI 1.34-1.58),中位受孕时间19个月 vs 36个月;在无严重女性因素的自然受孕亚组中TPMC阈值为20百万。精液参数高于WHO参考值时受孕率与受孕时间仍持续改善,TPMC高达100-150百万仍与更好结局相关。

要点

  • TPMC≥50百万与5年内受孕几率提高45%及更短受孕时间相关。
  • 无严重女性因素的自然受孕夫妇中,TPMC最佳阈值为20百万。
  • 精液参数高于WHO参考值后,受孕率和受孕时间仍持续改善。

核心结论

  • TPMC 50百万是预测亚fertile夫妇5年内更早受孕的最佳阈值。
  • 精子总数、浓度和前向运动力高于WHO参考值时仍与更好受孕结局相关。
  • TPMC高达100-150百万仍与更佳受孕率和受孕时间相关。

研究设计与样本

  • 纵向队列研究,纳入2002-2017年6061名亚fertile男性,均接受初始精液分析。
  • 自然受孕亚组5126人,无严重女性因素的自然受孕亚组3753人。
  • 采用Cox比例风险模型和回归树方法分析阈值。

主要发现

  • 总体中位受孕时间22个月(95%CI 21-23),3957对夫妇(65%)5年内受孕。
  • TPMC≥50百万者调整后5年内受孕HR为1.45(95%CI 1.34-1.58)。
  • TPMC≥50百万者中位受孕时间19个月(95%CI 18-20),<50百万者为36个月(95%CI 32-41)。
  • 无严重女性因素的自然受孕亚组中TPMC阈值为20百万。

关键数值与推荐

  • 总体队列TPMC最佳区分阈值为50百万。
  • 无严重女性因素的自然受孕队列TPMC阈值为20百万。
  • TPMC≥50百万者5年内受孕几率提高45%(HR 1.45, 95%CI 1.34-1.58)。

临床怎么用

  • 精液分析结果可用于向亚fertile夫妇咨询5年内受孕概率。
  • 对于精液参数低于WHO参考值但未达异常者,可考虑优化精液参数以改善受孕结局。
  • TPMC可作为评估男性不育严重程度的指标。

局限性

  • 女性伴侣信息有限,可能低估或误判女性不育诊断。
  • 缺乏医疗网络外助孕结局的详细信息,可能误编码为自然受孕。
  • 仅使用初始精液分析,未纳入精子形态学分析。
  • 缺乏关于受孕尝试连续性的信息,可能影响受孕时间数据。
  • 多数夫妇在初始精液分析前已尝试受孕超过12个月,可能低估受孕时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What thresholds for total sperm count, sperm concentration, progressive motility, and total progressive motile sperm count (TPMC) are associated with earlier time-to-conception in couples undergoing fertility evaluation? SUMMARY ANSWER: Values well above the World Health Organization (WHO) references for total sperm count, concentration, and progressive motility, and values up to 100 million for TPMC were consistently associated with earlier time-to-conception and higher conception rates. WHAT IS KNOWN ALREADY: Although individual semen parameters are generally not able to distinguish between fertile and infertile men, they can provide clinically useful information on time-to-pregnancy for counseling patients seeking fertility treatment. Compared to the conventional semen parameters, TPMC might be a better index for evaluating the severity of male infertility. STUDY DESIGN, SIZE, DURATION: We used data from a longitudinal cohort study on subfertile men from 2002 to 2017 and included 6061 men with initial semen analysis (SA) in the study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Men from subfertile couples who underwent a SA within the study period were included, and 5-year follow-up data were collected to capture conception data. Couples were further categorized into two subgroups: natural conception (n = 5126), after separating those who achieved conception using ART or IUI; natural conception without major female factor (n = 3753), after separating those with severe female factor infertility diagnoses. TPMC was calculated by multiplying the semen volume (ml) by sperm concentration (million/ml) and the percentage of progressively motile sperm (%). Cox proportional hazard models were used to report hazard ratios (HRs) with 95% CIs before and after adjusting for male age, the number of previous children before the first SA, and income. Using the regression tree method, we calculated thresholds for total sperm count, sperm concentration, progressive motility, and TPMC to best differentiate those who were more likely to conceive within 5 years after first SA from those less likely to conceive. We also plotted continuous values of semen parameters in predicting 5-year conception rates and time-to-conception. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, the median time to conception was 22 months (95% CI: 21-23). A total of 3957 (65%) couples were known to have achieved conception within 5 years of the first SA. These patients were younger and had higher values of sperm concentration, progressive motility, and TPMC. In the overall cohort, a TPMC of 50 million best differentiated men who were more likely to father a child within 5 years. Partners of men with TPMC ≥50 million had a 45% greater chance of conception within 5 years in the adjusted model (HR: 1.45; 95% CI: 1.34-1.58) and achieved pregnancy earlier compared to those men with TPMC < 50 million (median 19 months (95% CI: 18-20) versus 36 months (95% CI: 32-41)). Similar results were observed in the natural conception cohort. For the natural conception cohort without major female factor, the TPMC cut-off was 20 million. In the visual assessment of the graphs for the continuous semen parameter values, 5-year conception rates and time-to-conception consistently plateaued at higher values of sperm concentration, total sperm count, progressive motility, and TPMC compared to the WHO reference levels and our calculated thresholds. For TPMC, values up to 100-150 million were still associated with a better conception rate and time-to-conception in the visual assessment of the curves. LIMITATIONS, REASONS FOR CAUTION: There was limited information on female partners and potential for inaccuracies in capturing less severe female infertility diagnoses. Also we lacked details on assisted pregnancies achieved outside of our healthcare network (with possible miscoding as 'natural conception' in our cohort). We only used the initial SA and sperm morphology, another potentially important parameter, was not included in the analyses. We had no information on continuity of pregnancy attempts/intention, which could affect the time-to-conception data. Finally, most couples had been attempting conception for >12 months prior to initiating fertility treatment, so it is likely that we are underestimating time to conception. Importantly, our data might lack the generalizability to other populations. WIDER IMPLICATIONS OF THE FINDINGS: Our results suggest that a TPMC threshold of 50 million sperm provided the best predictive power to estimate earlier time-to-conception in couples evaluated for male factor infertility. Higher values of sperm count, concentration and progressive motility beyond the WHO references were still associated with better conception rates and time-to-conception. This provides an opportunity to optimize semen parameters in those with semen values that are low but not abnormal according to the WHO reference values. These data can be used to better inform patients regarding their chances of conception per year when SA results are used for patient counseling. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Keihani S, Verrilli LE, Zhang C, et al. Semen parameter thresholds and time-to-conception in subfertile couples: how high is high enough? Hum Reprod. 2021. PMID: 34097024. doi:10.1093/humrep/deab133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。